Skip to main content
Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
3.600
-0.070 (-1.91%)
At close: Feb 27, 2026, 4:00 PM EST
3.630
+0.030 (0.83%)
After-hours: Feb 27, 2026, 4:04 PM EST

Pluri Revenue

Pluri had revenue of $198.00K in the quarter ending December 31, 2025, with 7.03% growth. This brings the company's revenue in the last twelve months to $1.34M, up 97.49% year-over-year. In the fiscal year ending June 30, 2025, Pluri had annual revenue of $1.34M with 309.82% growth.

Revenue (ttm)
$1.34M
Revenue Growth
+97.49%
P/S Ratio
27.02
Revenue / Employee
$9,430
Employees
142
Market Cap
36.18M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20251.34M1.01M309.82%
Jun 30, 2024326.00K39.00K13.59%
Jun 30, 2023287.00K53.00K22.65%
Jun 30, 2022234.00K--
Jun 30, 2021---
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Celularity 40.58M
NovaBay Pharmaceuticals 10.30M
Palatin Technologies 8.96M
CervoMed 6.16M
Lisata Therapeutics 1.07M
Outlook Therapeutics 205.70K
Actinium Pharmaceuticals 90.00K
Revenue Rankings

PLUR News

More News